4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineethanol hydrochloride, 1g

1-Cyclopropylimidazolidin-2-one, 95%, 250mg

(1R*,4R*)-N1-(2-Nitrobenzyl)cyclohexane-1,4-diamine dihydrochloride, 1g

Benzyl methyl ether, 95.0%, 5g

N4-Acetylcytidine>95.0%(HPLC)(T)25g

Tubes à centrifuger sans métal, 15 ml, rack, 500 pièce(s)

4-(4-BENZYL-1-PIPERAZINYL)BENZOIC ACID, 97%, 1g

Methyl 4-amino-1H-pyrazole-3-carboxylate, 95.0%, 25g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-one, 97%, 1g

N-Hydroxy-2-m-tolyloxy-acetamidine, 95.0%, 1g

(+)-4-Fluorotartranilic acid, 5g

n,n-Dimethyl-4-oxo-4-(p-tolyl)butanamide, 97%, 100mg

1-Methylcyclohexanol, 95.0%, 25g